Flosonics awarded $70m BARDA contract for wearable’s advance into trauma care
Flosonics has won a contract worth up to $70m from the US Department of Health and Human Services’ (HHS) Biomedical…
02 Sep 2026
Vara nets first CE mark for autonomous AI breast cancer screening tool
Vara has secured a European CE mark for an autonomous, artificial intelligence (AI)-powered breast cancer screening triage tool – marking the first time a device of this nature has secured…
02 Sep 2026
Health Canada issues licences to Fujirebio’s Lumipulse assays
HU Group Holdings’ wholly owned subsidiary Fujirebio has received Class II Medical Device Licences from Health Canada for its Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays.…
02 Sep 2026
Medtronic raises FY27 outlook after reporting strong Q1 growth
Medtronic has reported revenues of around $9.8bn in Q1 of fiscal year 2027 (FY27) driven by double-digit growth across its key business segments, prompting the company to raise its FY27…
02 Sep 2026
FDA grants 510(k) clearance to Medibyt’s CPETWise solution
Israeli digital health company Medibyt has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CPETWise solution, which assists with the analysis and interpretation of cardiopulmonary…
01 Sep 2026
ESC 2026: Abbott presents positive longer-term dual ablation catheter data
New data from Abbott has demonstrated longer-term safety and effectiveness of its TactiFlex Duo ablation catheter in treating atrial fibrillation (AFib), building on the system’s previous six-month clinical outcomes data.…
01 Sep 2026
ESC 2026: Biomarker indicates coronary inflammation from non-contrast CT
New research led by the University of Oxford has validated Caristo Diagnostics’ fat attenuation index-score (FAI) biomarker’s role in coronary inflammation assessment, suggesting future applications for the company’s CaRi-Heart technology. Findings…